University of Paris
University of Paris is a French research-intensive, multidisciplinary university ranking 65th worldwide and among the top 50 worldwide universities in medical sciences (Academic Ranking of World Universities, and the most cited French university, author of 10% of all French scientific publications. Founded in 2019 from mother universities Paris-Descartes and Paris-Diderot, University of Paris cultivates a strong tradition of excellent research in health and medicine, thriving on novel diagnostic and therapeutic approaches in a global, high-standard environment. University of Paris is also the first partner of National Institute for Health (Inserm), hosting 25% of the total Inserm research staff in joint research units . A founding member of the European University Alliance Circle U., University of Paris was awarded in 2020 the French National seal of excellence (IdEx) and obtained the Human Resources Strategy for Researchers (HRS4R) label. This high profile, international research environment and the institutional framework boosting researchers’ careers and networks are key elements of its attractiveness to young European researchers.
Prof Laurence Legeai-Mallet
Supervisor of DC6. Prof vLegeai-Mallet is the head of the Molecular and Physiopathological basis of osteochondrodysplasia laboratory. Her research field ranges from identification of disease genes involved in cartilage and bone diseases, in understanding bone development and skeketal diseases to the development of therapeutic approaches. In 2009, she initiated pre-clinical studies for osteochondrodysplasias through collaboration in both academic chemistry laboratory and several pharmaceutical companies. In 2012, in collaboration with BioMarin, she reported the 1st investigational therapy for achondroplasia.